10x Genomics, Inc.

10x Genomics has reported zero cyber incidents and zero material red-flag 8-K filings in the past 90 days, suggesting operational stability in the immediate window. However, low signal in a 90-day snapshot does not indicate low structural risk—the company operates in a capital-intensive genomics market where financing dynamics and shareholder dilution patterns carry material weight. The full $49 Report extends analysis across 12 months of 8-K filings, calculates dilution risk from equity issuances, maps the complete financing history, and flags AI-related competitive and valuation signals absent from standard disclosures. The full $49 Report adds quantified dilution risk scoring, 8-K event context and trajectory, financing runway assessment, and AI disruption exposure analysis.